跳至主要内容
临床试验/ACTRN12618000413224
ACTRN12618000413224招募中3 期

The efficacy and mechanisms of action of N-acetylcysteine as an adjunct treatment for first episode psychosis.

Orygen, The National Centre of Excellence in Youth Mental Health0 个研究点目标入组 162 人开始时间: 2018年3月21日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
162

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
15 Years 至 25 Years(—)
性别
All

入选标准

  • i.Aged 15 to 25 years at time of study enrolment;
  • ii.Treatment stability: at least two weeks of stability in the use of primary medication
  • (e.g., anti-psychotic medications)
  • iii.Within their first three months of admission to the Early Psychosis Prevention and
  • Intervention Centre (EPPIC); and
  • iv.Capacity to consent to the study and comply with study procedures.

排除标准

  • i.Previous episode of psychosis or previously been treated with an anti-psychotic
  • prior to entry to the program;
  • ii.Known or suspected clinically relevant systemic medical disorder;
  • iii.Females who are pregnant or lactating;
  • iv.Prior sensitivity or allergy to NAC;
  • v.Currently enrolled in another research study
  • vi.Inability to comply with either the requirements of informed consent or the treatment
  • protocol; and/or
  • vii.Non-fluency in English

研究者

发起方
Orygen, The National Centre of Excellence in Youth Mental Health

相似试验